Trial intelligence / Profile preview

Sertraline and Naltrexone for Alcohol Dependence and Depression

NCT00004554Phase 4Completed

Sponsor
University of Pennsylvania
Start
Jan 2000
Primary completion
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sertraline, naltrexone in alcohol dependence, major depressive disorder (MDD), sponsored by University of Pennsylvania. Started Jan 2000; status: completed.

02

Drugs

sertralinenaltrexone
03

Conditions

alcohol dependencemajor depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00004554.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004554.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call